Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2020-08-27 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
2020年半年度募集资金存放与使用情况的专项报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2020年半年度募集资金存放与使用情况的专项报告" which translates to "2020 Semi-Annual Special Report on the Deposit and Use of Raised Funds." It details the amount of funds raised, their usage over multiple years, the balance of funds, management and regulatory compliance related to the raised funds, and investment of idle funds. It includes detailed financial figures and tables about the use of raised capital, investment projects, and changes in project implementation. The document is a comprehensive report on the use and management of capital raised by the company during a half-year period, containing substantive financial data and analysis. This fits the definition of an Interim / Quarterly Report (IR), as it is a comprehensive financial report for a period shorter than a full fiscal year and contains actual financial statements and substantive financial data and analysis. It is not merely an announcement or certification, nor is it a full annual report or earnings release. Therefore, the correct classification is IR with high confidence. H1 2020
2020-08-27 Chinese
关于间接控股股东股份变动重大事项的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a significant change in shareholding by an indirect controlling shareholder. It discusses the planned transfer of shares by the actual controller through a public listing on a property rights trading institution, which may lead to a change in the company's actual controller. The document includes risk warnings and procedural notes about the transaction's uncertainty. It does not contain financial statements, audit information, or detailed financial data. It is not a report but an announcement about a major shareholding change. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is short (1119 characters), consistent with an announcement rather than a full report.
2020-08-26 Chinese
关于更换持续督导保荐代表人的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of the continuous supervision sponsor representative for a company's non-public stock issuance project. It details the replacement of a sponsor representative due to work changes and the continuation of supervision responsibilities related to the use of raised funds. There is no financial data, earnings information, or detailed report content. The document is a regulatory announcement about management/supervisory personnel changes related to financing activities but does not report on the financing itself. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-08-17 Chinese
关于间接控股股东签署合作协议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about a cooperation agreement signed by its indirect controlling shareholder. It details the parties involved, the shareholding structure, and the strategic intent behind the cooperation. There is no financial data, no report attached or referenced as being published, and no mention of an annual or interim report. The document is a formal announcement of a corporate transaction related to shareholding and cooperation agreements, but it is not a merger or acquisition filing per se, nor a financing update. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about a shareholder cooperation agreement and related corporate information that does not fit other specific categories.
2020-08-04 Chinese
关于使用部分闲置自有资金进行理财管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the progress of using part of its idle funds for financial management, specifically investing in a structured deposit product. It details the investment amount, product type, risk control measures, and approvals by the board and supervisory committee. The document does not contain financial statements or detailed financial results but is a disclosure about a financing activity involving the company's own funds. It is not a full financial report, earnings release, or audit report. The content fits best under Capital/Financing Update (CAP) as it relates to the company's use of capital for investment purposes and updates shareholders on this activity.
2020-07-30 Chinese
第九届监事会临时会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a resolution passed at a temporary supervisory board meeting of the company. It details the approval of a proposal regarding the use of idle funds for financial management. There is no indication of it being a full financial report, audit report, or earnings release. It is not a notice of voting results from a general meeting but rather a board-level decision announcement. The document is short (795 characters) and focuses on a specific internal decision. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2020-07-13 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.